$SNYNF News Article - Press Release: Phase 2 data
Post# of 9
(Total Views: 79)
Posted On: 02/15/2024 8:20:46 AM
$SNYNF News Article - Press Release: Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MS https://marketwirenews.com/news-releases/pres...04198.html
(0)
(0)Sanofi-Aventis Sa (SNYNF) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼